USA Financial Formulas’s ArcBest ARCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-657
Closed -$94.3K – 403
2026
Q2
$94.3K Buy
657
+498
+313% +$64.8K 0.02% 187
2026
Q1
$15.6K Buy
159
+147
+1,225% +$13.9K ﹤0.01% 276
2025
Q4
$890 Buy
+12
New +$854 ﹤0.01% 307
2024
Q2
– Sell
-468
Closed -$66.7K – 306
2024
Q1
$66.7K Buy
+468
New +$61.3K 0.01% 228
2022
Q1
– Sell
-845
Closed -$101K – 353
2021
Q4
$101K Buy
+845
New +$86K 0.09% 120
2021
Q3
– Sell
-2,180
Closed -$127K – 402
2021
Q2
$127K Sell
2,180
-613
-22% -$43.9K 0.11% 156
2021
Q1
$197K Sell
2,793
-996
-26% -$57.4K 0.16% 122
2020
Q4
$162K Buy
+3,789
New +$144K 0.13% 135
2019
Q1
– Sell
-7,841
Closed -$381K – 135
2018
Q4
$381K Sell
7,841
-322
-4% -$12.5K 0.09% 157
2018
Q3
$373K Buy
+8,163
New +$383K 0.09% 175

Other funds holding ARCB

USA Financial Formulas's ARCB Position: Q3 2026 in Review

USA Financial Formulas sold out of ArcBest (ARCB) in Q3 2026, closing a stake of 657 shares — an estimated $94.3K sold.

USA Financial Formulas first reported a position in ARCB in Q3 2018 and held it in 10 quarters. The position peaked at $381K in Q4 2018. 122 funds tracked by Wall St. Rank hold ARCB as of Q3 2026.

  • USA Financial Formulas reported no remaining ArcBest position as of Q3 2026 after selling out during the quarter.
  • USA Financial Formulas sold 657 ArcBest shares in Q3 2026, an estimated $94.3K.
  • USA Financial Formulas first reported a position in ArcBest in Q3 2018 and held it in 10 quarters.
  • USA Financial Formulas's ArcBest position peaked at $381K in Q4 2018.
  • 122 funds tracked by Wall St. Rank held ArcBest as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.